Plenary Talk: Valeant’s Approach to Innovation
Valeant Pharmaceuticals is undergoing increased scrutiny. A year ago, J. Michael Pearson, then president and CEO, laid out the company’s vision for developing new tools in ophthalmology.
J. Michael Pearson
Mr. Pearson has been the CEO and serving on the Board since September 2010 and the Chairman of the Board since March 2011.